Literature DB >> 23702832

Relative quantification of proteasome activity by activity-based protein profiling and LC-MS/MS.

Nan Li1, Chi-Lin Kuo, Guillem Paniagua, Hans van den Elst, Martijn Verdoes, Lianne I Willems, Wouter A van der Linden, Mark Ruben, Eric van Genderen, Jacob Gubbens, Gilles P van Wezel, Herman S Overkleeft, Bogdan I Florea.   

Abstract

Activity-based protein profiling (ABPP) is a functional proteomics technique for directly monitoring the expression of active enzymes in cell extracts and living cells. The technique relies on irreversible inhibitors equipped with reactive groups (warheads) that covalently attach to the active site of enzymes and fluorescent or affinity tags for imaging and purification purposes, respectively. Here, a high-throughput and robust protocol for high-resolution quantitative activity-based proteasome profiling is described. We use both panreactive and subunit-specific fluorescent activity-based probes (ABPs) to quantify the proteasome activity in living cells, in the presence or absence of the potent proteasome inhibitor bortezomib. Active proteasome subunits from cell lysates are affinity-purified via a biotinylated ABP. Purification from live cells involves a two-step ABP approach using a reagent with a cell-permeable azide-warhead and postlysis installation of biotin. By means of liquid chromatography-mass spectrometry (LC-MS)-based proteomics, we can accurately identify the enriched proteins and the active site peptides of the enzymes, and relatively quantify all the proteasome activities in one experiment. The fluorescence ABPP protocols takes 2-3 d, and approximately 8-10 d are needed to complete the entire protocol.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23702832     DOI: 10.1038/nprot.2013.065

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  40 in total

1.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)--a general method for mapping sites of probe modification in proteomes.

Authors:  Eranthie Weerapana; Anna E Speers; Benjamin F Cravatt
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 3.  Catalytic mechanism and assembly of the proteasome.

Authors:  António J Marques; R Palanimurugan; Ana C Matias; Paula C Ramos; R Jürgen Dohmen
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

Review 4.  Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

Authors:  Robert C Kane; Peter F Bross; Ann T Farrell; Richard Pazdur
Journal:  Oncologist       Date:  2003

5.  Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells.

Authors:  T Rückrich; M Kraus; J Gogel; A Beck; H Ovaa; M Verdoes; H S Overkleeft; H Kalbacher; C Driessen
Journal:  Leukemia       Date:  2009-02-19       Impact factor: 11.528

6.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

8.  Proteasome activity profiling: a simple, robust and versatile method revealing subunit-selective inhibitors and cytoplasmic, defense-induced proteasome activities.

Authors:  Christian Gu; Izabella Kolodziejek; Johana Misas-Villamil; Takayuki Shindo; Tom Colby; Martijn Verdoes; Kerstin H Richau; Jürgen Schmidt; Hermen S Overkleeft; Renier A L van der Hoorn
Journal:  Plant J       Date:  2009-12-23       Impact factor: 6.417

9.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.

Authors:  Tony Muchamuel; Michael Basler; Monette A Aujay; Erika Suzuki; Khalid W Kalim; Christoph Lauer; Catherine Sylvain; Eileen R Ring; Jamie Shields; Jing Jiang; Peter Shwonek; Francesco Parlati; Susan D Demo; Mark K Bennett; Christopher J Kirk; Marcus Groettrup
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440

10.  Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.

Authors:  Alexander Adibekian; Brent R Martin; Chu Wang; Ku-Lung Hsu; Daniel A Bachovchin; Sherry Niessen; Heather Hoover; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2011-05-15       Impact factor: 15.040

View more
  28 in total

Review 1.  Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection.

Authors:  Julie A Reisz; Nidhi Bansal; Jiang Qian; Weiling Zhao; Cristina M Furdui
Journal:  Antioxid Redox Signal       Date:  2014-02-21       Impact factor: 8.401

2.  Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification.

Authors:  Eva J van Rooden; Bogdan I Florea; Hui Deng; Marc P Baggelaar; Annelot C M van Esbroeck; Juan Zhou; Herman S Overkleeft; Mario van der Stelt
Journal:  Nat Protoc       Date:  2018-03-22       Impact factor: 13.491

3.  Activity-based probes for functional interrogation of retaining β-glucuronidases.

Authors:  Liang Wu; Jianbing Jiang; Yi Jin; Wouter W Kallemeijn; Chi-Lin Kuo; Marta Artola; Wei Dai; Cas van Elk; Marco van Eijk; Gijsbert A van der Marel; Jeroen D C Codée; Bogdan I Florea; Johannes M F G Aerts; Herman S Overkleeft; Gideon J Davies
Journal:  Nat Chem Biol       Date:  2017-06-05       Impact factor: 15.040

4.  The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells.

Authors:  Marianne Kraus; Juergen Bader; Paul P Geurink; Emily S Weyburne; Anne C Mirabella; Tobias Silzle; Tamer B Shabaneh; Wouter A van der Linden; Gerjan de Bruin; Sarah R Haile; Eva van Rooden; Christina Appenzeller; Nan Li; Alexei F Kisselev; Herman Overkleeft; Christoph Driessen
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

5.  26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase.

Authors:  Donghoon Lee; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-15       Impact factor: 12.779

6.  Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).

Authors:  Christoph Driessen; Marianne Kraus; Markus Joerger; Hilde Rosing; Jürgen Bader; Felicitas Hitz; Catherine Berset; Alexandros Xyrafas; Hanne Hawle; Gregoire Berthod; Hermann S Overkleeft; Christiana Sessa; Alwin Huitema; Thomas Pabst; Roger von Moos; Dagmar Hess; Ulrich J M Mey
Journal:  Haematologica       Date:  2015-12-11       Impact factor: 9.941

7.  Proteins containing ubiquitin-like (Ubl) domains not only bind to 26S proteasomes but also induce their activation.

Authors:  Galen A Collins; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

8.  A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.

Authors:  Scott Lovell; Leran Zhang; Thomas Kryza; Anna Neodo; Nathalie Bock; Elena De Vita; Elizabeth D Williams; Elisabeth Engelsberger; Congyi Xu; Alexander T Bakker; Maria Maneiro; Reiko J Tanaka; Charlotte L Bevan; Judith A Clements; Edward W Tate
Journal:  J Am Chem Soc       Date:  2021-06-04       Impact factor: 16.383

9.  Expanding the chemical space for natural products by Aspergillus-Streptomyces co-cultivation and biotransformation.

Authors:  Changsheng Wu; Boris Zacchetti; Arthur F J Ram; Gilles P van Wezel; Dennis Claessen; Young Hae Choi
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

10.  A chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing.

Authors:  Cui Liu; Yanbao Yu; Feng Liu; Xin Wei; John A Wrobel; Harsha P Gunawardena; Li Zhou; Jian Jin; Xian Chen
Journal:  Nat Commun       Date:  2014-12-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.